The Fiji Times » Bristol Myers must face $6 4 billion lawsuit over delayed cancer drug fijitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fijitimes.com Daily Mail and Mail on Sunday newspapers.
New York: A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to av.
11 Min Read
(Reuters) - Chancellor Andre Bouchard of Delaware Chancery Court ruled Monday that WeWork cannot voluntarily dismiss a lawsuit accusing Softbank and Vision Fund of breaching a multi-pronged agreement in which the defendants pledged to complete a $3 billion tender offer for WeWork shares in addition to providing financing to the struggling company.
Bouchard’s ruling resolved an extraordinarily unusual dispute over corporate control. The lawsuit was filed on the company’s behalf last April, after Softbank ditched the tender offer, by a special committee comprised of the two WeWork board members who had negotiated the SoftBank deal. At the time of the filing, the special committee had the backing of the company’s outside counsel at